Barriers to new drug development in respiratory disease

Peter J Barnes¹, Sergio Bonini², Werner Seeger³, Maria G Belvisi⁴, Brian Ward⁵, Anthony Holmes⁶

Affiliations

¹ Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK p.j.barnes@imperial.ac.uk.
² Second University of Naples, Caserta, Italy Institute of Translational Pharmacology-CNR, Rome, Italy European Medicines Agency, London, UK.
³ University of Giessen and Marburg Lung Centre, Member of the German Centre for Lung Research (DZL), Giessen, Germany.
⁴ Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
⁵ European Affairs Dept, European Respiratory Society, Brussels, Belgium.
⁶ National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.

PMID: 25931481
DOI: 10.1183/09031936.00007915

Free article

Editorial

Barriers to new drug development in respiratory disease

Peter J Barnes et al. Eur Respir J. 2015 May.

Free article

. 2015 May;45(5):1197-207.

doi: 10.1183/09031936.00007915.

Authors

Peter J Barnes¹, Sergio Bonini², Werner Seeger³, Maria G Belvisi⁴, Brian Ward⁵, Anthony Holmes⁶

Affiliations

¹ Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK p.j.barnes@imperial.ac.uk.
² Second University of Naples, Caserta, Italy Institute of Translational Pharmacology-CNR, Rome, Italy European Medicines Agency, London, UK.
³ University of Giessen and Marburg Lung Centre, Member of the German Centre for Lung Research (DZL), Giessen, Germany.
⁴ Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
⁵ European Affairs Dept, European Respiratory Society, Brussels, Belgium.
⁶ National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.

PMID: 25931481
DOI: 10.1183/09031936.00007915

No abstract available

PubMed Disclaimer

Cited by

PerfuPul-A Versatile Perfusable Platform to Assess Permeability and Barrier Function of Air Exposed Pulmonary Epithelia.
Carius P, Dubois A, Ajdarirad M, Artzy-Schnirman A, Sznitman J, Schneider-Daum N, Lehr CM. Carius P, et al. Front Bioeng Biotechnol. 2021 Oct 6;9:743236. doi: 10.3389/fbioe.2021.743236. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34692661 Free PMC article.
Innovative three-dimensional models for understanding mechanisms underlying lung diseases: powerful tools for translational research.
Nizamoglu M, Joglekar MM, Almeida CR, Larsson Callerfelt AK, Dupin I, Guenat OT, Henrot P, van Os L, Otero J, Elowsson L, Farre R, Burgess JK. Nizamoglu M, et al. Eur Respir Rev. 2023 Jul 26;32(169):230042. doi: 10.1183/16000617.0042-2023. Print 2023 Sep 30. Eur Respir Rev. 2023. PMID: 37495250 Free PMC article. Review.
Chronic lung diseases: prospects for regeneration and repair.
Barnes PJ, Anderson GP, Fagerås M, Belvisi MG. Barnes PJ, et al. Eur Respir Rev. 2021 Jan 6;30(159):200213. doi: 10.1183/16000617.0213-2020. Print 2021 Mar 31. Eur Respir Rev. 2021. PMID: 33408088 Free PMC article. Review.
A Heterotopic Xenograft Model of Human Airways for Investigating Fibrosis in Asthma.
Hackett TL, Ferrante SC, Hoptay CE, Engelhardt JF, Ingram JL, Zhang Y, Alcala SE, Shaheen F, Matz E, Pillai DK, Freishtat RJ. Hackett TL, et al. Am J Respir Cell Mol Biol. 2017 Mar;56(3):291-299. doi: 10.1165/rcmb.2016-0065MA. Am J Respir Cell Mol Biol. 2017. PMID: 27788019 Free PMC article.
Human Multi-Compartment Airways-on-Chip Platform for Emulating Respiratory Airborne Transmission: From Nose to Pulmonary Acini.
Nof E, Zidan H, Artzy-Schnirman A, Mouhadeb O, Beckerman M, Bhardwaj S, Elias-Kirma S, Gur D, Beth-Din A, Levenberg S, Korin N, Ordentlich A, Sznitman J. Nof E, et al. Front Physiol. 2022 Mar 8;13:853317. doi: 10.3389/fphys.2022.853317. eCollection 2022. Front Physiol. 2022. PMID: 35350687 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Barriers to new drug development in respiratory disease

Affiliations

Barriers to new drug development in respiratory disease

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources